FDA reclassifies Mallinckrodt’s ADHD generic drug, sending shares down
November 13, 2014 at 15:16 PM EST
Mallinckrodt said Thursday that the Food and Drug Administration reclassified its generic attention-deficit hyperactivity disorder drug...